Skip to content

Clinical trials

Phase 4 Depressive Disorder trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Depressive Disorder Phase: Phase 4 Country / region: United States Clear all

34 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20021
20032
20043
20052
20062
20072
20101
20121
20133
20152
20161
20172
20181
20191
20212
20221
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed26
Terminated4
Recruiting2
Suspended1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
New York State Psychiatric Institute5
University of Pittsburgh4
University of North Carolina, Chapel Hill3
Massachusetts General Hospital2
Mayo Clinic2
National Institute of Mental Health (NIMH)2
Washington University School of Medicine2
Weill Medical College of Cornell University2
Cambridge Health Alliance1
Eli Lilly and Company1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Depressive Disorder34
Major Depressive Disorder10
Bipolar Disorder5
Mood Disorders5
Mental Disorders3
Dysthymic Disorder2
Anhedonia1
Anxiety Disorders1
Cognitive Dysfunction1
Depressive Disorder, Treatment-Resistant1

Trials

Showing 1 to 25 of 34. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.